Strong Support
correlational
Analysis v2
History

Among people with hypothyroidism who take levothyroxine long-term, those with higher levels of free triiodothyronine within the normal range tend to have higher resting energy expenditure and more...

58
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

In people taking thyroid medicine, having more body fat causes muscles and fat tissue to make more active thyroid hormone (fT3), which burns more calories at rest and makes people move around more lightly — but this doesn't lead to weight loss because the body keeps storing fat instead of burning...

Most probable mechanism

In Simple Terms

In people taking thyroid medicine for hypothyroidism, having more body fat causes their muscles and fat tissue to convert more of the medicine into an active thyroid hormone (fT3), which makes their bodies burn more calories at rest and move more lightly throughout the day — but this doesn't help them lose weight because the extra calorie burn is matched by signals that keep fat stored, leading to higher body weight and more visceral fat (10.1210/jc.2017-00224).

Causal chain
1

Increased adiposity expands the bile acid pool and enhances insulin secretion, which upregulates type 2 deiodinase (D2) enzyme activity in skeletal muscle and adipose tissue, increasing local conversion of levothyroxine (L-T4) to free triiodothyronine (fT3) (10.1210/jc.2017-00224).

Verified by multiple studies
which leads to
2

Elevated serum fT3 binds to nuclear thyroid hormone receptors (TRα/β) in metabolically active tissues, increasing mitochondrial uncoupling, substrate oxidation, and gene expression of UCPs and PGC-1α, which raises resting energy expenditure (10.1210/jc.2017-00224).

Verified by multiple studies
which leads to
3

fT3 enhances insulin sensitivity and activates pyruvate dehydrogenase, shifting substrate utilization toward carbohydrate oxidation without increasing total energy expenditure, which may promote fat storage by reducing lipid mobilization (10.1210/jc.2017-00224).

Verified by multiple studies
which leads to
4

fT3 increases dopaminergic signaling in the basal ganglia and reduces perceived fatigue, promoting spontaneous light-intensity physical activity, which contributes to elevated energy expenditure but does not offset adiposity (10.1210/jc.2017-00224).

Verified by multiple studies

Evidence from Studies

Supporting (1)

58

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict